Phase 1b/2 KEYNOTE-365 Cohort I: Pembrolizumab Plus Carboplatin and Etoposide Chemotherapy (Pembrolizumab-Chemotherapy) or Chemotherapy Alone for Metastatic Neuroendocrine Prostate Cancer (NEPC)
Loading...
Date
2025
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Open Access Color
OpenAIRE Downloads
OpenAIRE Views
Abstract
Description
Keywords
Fields of Science
Citation
WoS Q
Q4
Scopus Q
Q3
Source
Asia-Pacific Journal of Clinical Oncology
Volume
21
Issue
Start Page
119
End Page
119
